The Oncology Institute of Hope and Innovation is a clinical research site located in Los Angeles, California, United States 90033.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
The Oncology Institute of Hope and Innovation has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Non-Small-Cell Lung, Advanced Non-Small Cell Lung Cancer.
Sponsors: Pfizer, Regeneron Pharmaceuticals.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Oncology Institute of Hope and Innovation has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Oncology Institute of Hope and Innovation has 3 clinical trials on record, with 1 currently active. Their work covers Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Non-Small-Cell Lung, Advanced Non-Small Cell Lung Cancer.
The Oncology Institute of Hope and Innovation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.